Source: Eur Respir J 2006 Oct 01;28(4):703-711
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Liu C., Zuo J., Janssen L. J.. Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli. Eur Respir J 2006 Oct 01;28(4):703-711

Member's Comments

No comment yet.

Related content which might interest you: Experimental airways hyperreactivity and modulation of glutamatergic and nitrergic signalling Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Epac1 and Epac2 regulate airway smooth muscle tone in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action Year: 2016 Long-acting beta2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016 Potent bronchodilation and reduced stiffness by relaxant stimuli under dynamic conditions Source: Eur Respir J 2009; 33: 844-851 Year: 2009 Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Compound A modulates steroid insensitive chemokines in airway smooth muscle cells via IRF-1 dependent and independent pathways Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Estrogen requires the NO-cGMP-PKG pathway in order to prevent the hyper-responsiveness of asthmatic tracheal smooth muscle to carbachol Source: Annual Congress 2005 - Highlights of the 2005 ERS Lung Science Conference in Taormina Year: 2005 Activation of TRPV4 triggers ATP release and mast cell dependent contraction of airway smooth muscle (ASM) Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD Year: 2015 Involvement of the BK channels/G proteins processes in the synergistic effects between anticholinergic agents and beta2-adrenoceptor agonists in airway smooth muscle Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 TGF-beta alters TRPC6 expression and calcium handling via smad2/3 in human airway smooth muscle Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Platelets induce airway smooth muscle cell proliferation through mechanisms dependent on ROS and 5-LOX metabolites Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Extracellular matrix regulates human airway smooth muscle cell migration Source: Eur Respir J 2004; 24 : 545-551 Year: 2004 Beyond the dogma: novel β2-adrenoceptor signalling in the airways Source: Eur Respir J 2006; 27: 1286-1306 Year: 2006 The effect of adenosine on VEGF release from airway smooth muscle from subjects with asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 Relaxant effects of the Rho-kinase inhibitor Y-27632 in airway smooth muscle Source: Eur Respir J 2003; 22: Suppl. 45, 396s Year: 2003 NGF signalling pathways in human airway smooth muscle proliferation Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Rhinovirus-induced IL-33 expression in asthmatic airway smooth muscle cells is TLR3-dependent and involves activation of TAK1 Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis Year: 2016